Cost-effectiveness analysis of moxifloxacin and levofloxacin for treatment of urinary tract infection
Abstract
Objective To estimate the curative effect,adverse reaction and cost-effectiveness of moxifloxacin and levofloxacin for treatment of urinary tract infection.Methods The trial design was random,open,and parallel control.195 patients with urinary tract infection were involved.176 cases evaluated were randomly divided into the treatment group and the control group.90 patients in treatment group were given 400 mg moxifloxacin capsule for 10 d,while 86 patients in control group were given 200 mg levofloxacin capsule twice a day for 7-14 d.Results The total clinical effective rate of case and control group were 97.8% and 91.9% respectively,and the bacterial eliminating rate were 96.7% and 94.2% respectively,and the rate of adverse reaction were 7.78% and 9.30% respectively.There was no significant difference between two groups(P0.05).The cost-effectiveness ratio of moxifloxacin was 2.67 and 0.51 for levofloxacin(P0.01).Conclusion The therapeutic scheme of levofloxacin seems to be the best one for treating urinary tract infection.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.